Advertisement

Abstract

Facial hemangiomas present a special challenge for the medical profession. Nowadays parents are better informed via the world wide web and through patient support groups, leading them to demand the greatest attention and state of the art treatment for their child. Parents are faced with their children’s disfigurement daily and they experience the “rapid growing” vascular tumor as an increasing problem in their interactions with each other, their child and the community. In this chapter we address the different presentations of facial hemangiomas and the diagnostics and different state of the art treatment modalities available.

Keywords

Infantile Hemangioma Port Wine Stain Spastic Diplegia Capillary Malformation Facial Hemangioma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bauland CG, Steensel van MA, Steijlen PM et al (2006) The pathogenesis of hemangiomas: a review. Plas Reconstr Surg 117:29e–35eCrossRefGoogle Scholar
  2. 2.
    Mulliken JB, Glowacki J (1982) Hemangioma and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 69(3):412–422CrossRefPubMedGoogle Scholar
  3. 3.
    Haggstrom A, Lammer EJ, Schneider RA et al (2006) Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117:698–703CrossRefPubMedGoogle Scholar
  4. 4.
    Frieden IJ, Reese V, Cohen D (1996) PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 132(3):307–311CrossRefPubMedGoogle Scholar
  5. 5.
    Konez O, Burrows PE, Mulliken JB et al (2003) Angiographic features of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol 34(1):15–19CrossRefGoogle Scholar
  6. 6.
    Enjolras O, Mulliken JB, Boon LM et al (2001) Noninvoluting congenital hemangiomas: a rare cutaneous vascular anomaly. Plast Reconstr Surg 107:1647–1654CrossRefPubMedGoogle Scholar
  7. 7.
    Pope E, Krafchik BR, Macarthur C et al (2007) Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomised, controlled trial. Pediatrics 119:e1239–e1247CrossRefPubMedGoogle Scholar
  8. 8.
    Enjolras O, Riché MC, Merland JJ, Escande JP (1990) Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85:491–498PubMedGoogle Scholar
  9. 9.
    Enjolras O, Brevière GM, Roger G (2004) Vincristine treatment for function-and life-threatening infantile hemangioma. Archives de Pédiatrie 11:99–107CrossRefPubMedGoogle Scholar
  10. 10.
    Barlow CF, Priebe CJ, Mulliken JB et al (1998) Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 132(3):517–530Google Scholar
  11. 11.
    Batta K, Goodyear HM, Moss C et al (2002) Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood hemangiomas: results of a 1-year analysis. Lancet 360:521–527CrossRefPubMedGoogle Scholar
  12. 12.
    Stier MF, Glick SA, Hirsch RJ (2008) Laser treatment of pediatric vascular lesions: Port wine stains and hemangiomas. J Am Acad Dermatol 58:261–285CrossRefPubMedGoogle Scholar
  13. 13.
    Weiss AH, Kelly JP (2008) Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection. Ophthalmology 115(2):390–397CrossRefPubMedGoogle Scholar
  14. 14.
    Ranchod TM, Frieden IJ, Frederick DR (2005) Corticosteroid treatment of periorbital hemangioma of infancy: a review of the evidence. Br J Ophthalmol 89:1134–1138CrossRefPubMedGoogle Scholar
  15. 15.
    Faguer K, Dompmartin A, Labbe D et al (2002) Early surgical treatment of Cyrano-nose haemangiomas with Rethi incision. Br J Plast Surg 55(6):498–503CrossRefPubMedGoogle Scholar
  16. 16.
    Greene AK, Rogers GF, Mulliken JB (2004) Management of parotid hemangioma in 100 children. Plast Reconstr Surg 113(1):53–60CrossRefPubMedGoogle Scholar
  17. 17.
    Meeuwis J, Bos CE, Hoeve LJ, Voort van der E (1990) Subglottic hemangiomas in infants: treatment with intralesional corticosteroid injection and intubation. Int J Pediatr Otorhinolaryngol 19:145–150CrossRefPubMedGoogle Scholar
  18. 18.
    Enjolras O, Wassef M, Mazoyer E et al (1997) Infants with Kasabach-Merritt syndrome do not have “true” hemangioma. J Pediatr 130(4):631–64CrossRefPubMedGoogle Scholar
  19. 19.
    Haisley-Royster C, Enjolras O, Frieden IJ et al (2002) Kasabach-Merritt phenomenon: a retrospective study of treatment with Vincristine. J Pediatr Hematol Oncol 24(6):459–462CrossRefPubMedGoogle Scholar
  20. 20.
    Rieu PN, Mepschen M, Verhaak C, Spauwen PHM (2006) Facial hemangiomas: functional status and selfesteem of the child. Oral presentation during the 16th International Workshop on Vascular Anomalies of the International Society for the Study of Vascular Anomalies (ISSVA), Milan, June, pp 14–17Google Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Paul Rieu
    • 1
  1. 1.Department of SurgeryRadboud University Medical Center NijmegenNijmegenThe Netherlands

Personalised recommendations